Fenbendazole Research

Fenbendazole and Breast Cancer: Pyroptosis, Case Reports & What the Research Shows

A landmark 2025 study in Frontiers in Pharmacology revealed fenbendazole induces pyroptosis in breast cancer cells — a newly identified mechanism beyond microtubule disruption. We break down the science, a Stage IV case report, mouse model data, and safety considerations.

Fenbendazole Research Compounds

Fenbendazole vs Mebendazole for Cancer: Key Differences, Evidence, and Which to Choose

Fenbendazole and mebendazole belong to the same benzimidazole drug family, but differ significantly in human approval status, evidence base, cost, and clinical use. This guide breaks down both for researchers and patients exploring repurposed-drug cancer protocols.

Ivermectin Research

Ivermectin in Cancer Protocols: What the Research Shows

Educational research overview of ivermectin in investigational cancer protocols: ISOM Protocol, clinical trial NCT05318469, bioavailability considerations, drug interactions, and safety monitoring. For research and educational purposes only — not medical advice.

Methylene Blue Research

Methylene Blue in Cancer Research: PDT & Mechanisms

Exploring methylene blue in experimental oncology — from its redox chemistry and photodynamic therapy research to its place in emerging repurposed-drug protocols.

Curcumin Research

Curcumin and Cancer Research: Key Mechanisms Explained

Curcumin, the main bioactive polyphenol found in turmeric (Curcuma longa), has been widely studied for its biological activity, particularly in the context of cancer-related research. A comprehensive scientific review published in Anticancer Research.